Intestinal and hepatic lipid metabolism plays an essential role in regulating
plasma lipid levels. These lipids are mobilized on apolipoprotein B
(apoB)-containing lipoproteins and their plasma homeostasis is maintained by
balancing production and catabolism. Microsomal triglyceride transfer protein
(MTP) which is expressed mainly in the intestine and liver plays an essential
role in regulating the assembly and secretion of apoB-lipoproteins. Any imbalance
in the production or clearance of lipoproteins leads to hyperlipidemia which is a
major risk factor for atherosclerosis, obesity, diabetes, and metabolic syndrome.
Here, we identify a new role of inositol-requiring transmembrane
kinase/endoribonuclease 1 (IRE1) in the regulation of plasma
lipids. We generated intestine specific IRE1 knockout mice to study
whether intestinal IRE1 regulates plasma lipids by modulating
intestinal lipid absorption. Intestine specific deletion of Ire1a gene
in mice fed chow diet, significantly reduced plasma cholesterol and triglycerides
by 29% and 43% in Ire1a mice (P 0.01 &
P 0.001, respectively). These changes were not associated with any
alteration of MTP activity nor its mRNA expression. On the other hand, Western
diet increased plasma triglyceride by 37% (P 0.01) without
affecting total plasma cholesterol in Ire1a mice.
Interestingly, this effect was associated with a significant increase in the
intestinal MTP activity and its mRNA expression (25%, P 0.01 and
70%, P 0.05, respectively). Collectively, our findings reveal key
role of intestinal IRE1 in the regulation of plasma lipids that may
provide a therapeutic target for disorders of lipid metabolism.